Association between Episodes of Upper Respiratory Infection and Exacerbations in Adult Patients with Asthma

References

• Dougherty RH, Fahy JV. Acute exacerbations of asthma: Epidemiology, biology and the exacerbation-prone phenotype. Clin Exp Allergy 2009; 39:193–202.
   PubMed Web of Science ®Google Scholar
• Ten Brinke A, Sterk PJ, Masclee AA, Spinhoven P, Schmidt JT, Zwinderman AH, Rabe KF, Bel EH. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J 2005; 26:812–818.
   PubMed Web of Science ®Google Scholar
• Koga T, Oshita Y, Kamimura T, Koga H, Aizawa H. Characterisation of patients with frequent exacerbation of asthma. Respir Med 2006; 100:273–278.
   PubMed Web of Science ®Google Scholar
• Miller MK, Lee JH, Miller DP, Wenzel SE. TENOR Study Group. Recent asthma exacerbations: A key predictor of future exacerbations. Respir Med 2007; 101:481–489.
   PubMed Web of Science ®Google Scholar
• Lambert HP, Stern H. Infective factors in exacerbations of bronchitis and asthma. BMJ 1972; 3:323–327.
   PubMedGoogle Scholar
• Atmar RL, Guy E, Guntupalli KK, Zimmerman JL, Bandi VD, Baxter BD, Greenberg SB. Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med 1998; 158:2453–2459.
   PubMed Web of Science ®Google Scholar
• Beasley R, Coleman ED, Hermon Y, Holst PE, O’Donnel TV, Tobias M. Viral respiratory tract infection and exacerbations of asthma in adult patients. Thorax 1988; 43:679–683.
   PubMed Web of Science ®Google Scholar
• National Heart, Lung, and Blood Institute. Expert panel report 3: guidelines for the diagnosis and management of asthma – full report 2007. August 28, 2007. Available at: www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf. Accessed August 12, 2011.
   Google Scholar
• Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2009. Available at: http://www.ginasthma.org/pdf/GINA_Report_2010.pdf. Accessed August 12, 2011.
   Google Scholar
• Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: The Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16:802–807.
   PubMed Web of Science ®Google Scholar
• Barrett B, Locken K, Maberry R, Schwamman J, Brown R, Bobula J, Stauffacher EA. The Wisconsin Upper Respiratory Symptom Survey (WURSS): A new research instrument for assessing the common cold. J Fam Pract 2002; 51: 265.
   PubMed Web of Science ®Google Scholar
• Teichtahal H, Buckmaster N, Pertnihors E. The incidence of respiratory tract infection in adults requiring hospitalization for asthma. Chest 1997; 112:591–596.
   PubMed Web of Science ®Google Scholar
• Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, O’Byrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Sullivan SD, Szefler SJ, Thomas MD, Wenzel SE; American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An official American Thoracic Society/European Respiratory Society statement: Asthma control and exacerbations: Standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180:59–99.
   PubMed Web of Science ®Google Scholar
• Walter MJ, Castro M, Kunselman SJ, Chinchilli VM, Reno M, Ramkumar TP, Avila PC, Boushey HA, Ameredes BT, Bleecker ER, Calhoun WJ, Cherniack RM, Craiq TJ, Denlinger LC, Israel E, Fahy JT, Jarjour NN, Kraft M, Lazarus SC, Lemanske RF Jr, Martin RJ, Peters SP, Ramsdell JW, Sorknes CA, Sutherland ER, Szefler SJ, Wasserman SI, Wechsler ME; National Heart, Lung and Blood Institute’s Asthma Clinical Research Network. Predicting worsening asthma control following the common cold. Eur Respir J 2008; 32:1548–1554.
   PubMed Web of Science ®Google Scholar
• Corne JM, Marshall C, Smith S, Schreiber J, Sanderson G, Holgate ST, Johnston SL. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: A longitudinal cohort study. Lancet 2002; 359:831–834.
   PubMed Web of Science ®Google Scholar
• Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993; 307:982–986.
   PubMed Web of Science ®Google Scholar
• Hudgel DW, Langston Jr L, Selner JC, McIntosh K. Viral and bacterial infections in adults with chronic asthma. Am Rev Respir Dis 1979; 120:393–397.
   PubMed Web of Science ®Google Scholar
• Tarlo S, Broder I, Spence L. A prospective study of respiratory infection in adult asthmatics and their normal spouses. Clin Allergy 1979; 9:293–301.
   PubMedGoogle Scholar
• Turner RB. Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol 1997; 78: 531–539.
   PubMed Web of Science ®Google Scholar
• Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pederssen SE; GOAL Investigators Group. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004; 170:836–844.
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Löfdahl CG, Postma DS, Tattersfield AE, O’Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997; 337:1405–1411.
   PubMed Web of Science ®Google Scholar
• Dusser D, Montani D, Chanez P, de Blic J, Delacourt C, Deschildre A, Devillier P, Didier A, Leroyer C, Marguet C, Martinat Y, Piquet J, Raherison C, Serrier P, Tillie-Leblond I, Tonnel AB, Tunon de Lara M, Humbert M. Mild asthma: An expert review on epidemiology, clinical characteristics and treatment recommendations. Allergy 2007; 62:591–604.
   PubMed Web of Science ®Google Scholar
• Soriano JB, Rabe KF, Vermeire PA. Predictors of poor asthma control in European adults. J Asthma 2003; 40:803–813.
   PubMed Web of Science ®Google Scholar
• Temprano J, Mannino DM. The effect of sex on asthma control from the National Asthma Survey. J Allergy Clin Immunol 2009; 123:854–860.
   PubMed Web of Science ®Google Scholar
• Hermosa JL, Sánchez CB, Rubio MC, Mínguez MM, Walther JL. Factors associated with the control of severe asthma. J Asthma 2010; 47:124–130.
   PubMed Web of Science ®Google Scholar
• Krishnan V, Diette GB, Rand CS, Bilderback AL, Merriman B, Hansel NN, Krishman JA. Mortality in patients hospitalized for asthma exacerbations in the United States. Am J Respir Care Clin Med 2006; 174: 633–638.
   PubMed Web of Science ®Google Scholar
• Eisner MD, Yegin A, Trzaskoma B. Severity-of-asthma score predicts clinical outcomes in patients with moderate-to-severe persistent asthma. Chest 2011; doi:10.1378/chest.11–0020.
   Google Scholar
• Sin DD, Man J, Sharpe H, Gan WQ, Man SF. Pharmacological management to reduce exacerbations in adults with asthma: A systematic review and meta-analysis. J Am Med Assoc 2004; 292:367–376.
   PubMed Web of Science ®Google Scholar
• Salvi SS, Krishna MT, Sampson AP, Holgate ST. The anti-inflammatory effects of leukotriene-modifying drugs and their use in asthma. Chest 2001; 119:1533–1546.
   PubMed Web of Science ®Google Scholar
• Ringdal N, Eliraz A, Pruzinec R, Weber HH, Mulder PG, Akveld M, Bateman ED. International Study Group. The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma. Respir Med 2003; 97:234–241.
   PubMed Web of Science ®Google Scholar
• Reddel H, Ware S, Marks G, Salome C, Jenkins C, Woolcock A. Differences between asthma exacerbations and poor asthma control. Lancet 1999; 353:364–369.
   PubMed Web of Science ®Google Scholar
• Tattersfield AE, Postma DS, Barnes PJ, Svensson K, Bauer CA, O’Byrne PM, Löfdahl CG, Pauwels RA, Ullman A. Exacerbations of asthma: A descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med 1999; 160:594–599.
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Löfdahl CG, Postma DS, Tatterfield AE, O’Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997; 337:1405–1411.
   PubMed Web of Science ®Google Scholar
• Rosi E, Ronchi MC, Grazzini M, Duranti R, Scano G. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: Results of a factor analysis. J Allergy Clin Immunol 1999; 103:232–237.
   PubMed Web of Science ®Google Scholar
• Dimova-Yaneva D, Russell D, Main M, Brooker RJ, Helms PJ. Eosinophil activation and cysteinyl leukotriene production in infants with respiratory syncytial virus bronchiolitis. Clin Exp Allergy 2004; 34:555–558.
   PubMed Web of Science ®Google Scholar
• Wedde-Beer K, Hu C, Rodriguez M, Piedimonte G. Leukotrienes mediate neurogenic inflammation in lungs of young rats infected with respiratory syncytial virus. Am J Physiol Lung Cell Mol Physiol 2002; 282:L1143–L1150.
   PubMed Web of Science ®Google Scholar
• Bisgaard H. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med 2003; 167:379–383.
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Zielen S, Garcia-Garcia ML, Johnston SL, Gilles L, Menten J, Tozzi CA, Polos P. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 2005; 171:315–322.
   PubMed Web of Science ®Google Scholar
• Kloepfer KM, DeMore JP, Vrtis RF, Swenson CA, Gaworski KL, Bork JA, Evans MD, Gern JE. Effects of montelukast on patients with asthma after experimental inoculation with human rhinovirus 16. Ann Allergy Asthma Immunol 2011; 106:252–257.
   PubMed Web of Science ®Google Scholar
• Joos S, Miksch A, Szecsenyi J, Wieseler B, Grouven U, Kaiser T, Schneider A. Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: A systematic review. Thorax 2008; 63:453–462.
   PubMed Web of Science ®Google Scholar
• Price D, Musgrave SD, Shepstone L, Hillyer EV, Sims EJ, Gilbert RF, Juniper EF, Ayres JG, Kemp L, Blyth A, Wilson EC, Wolfe S, Freeman D, Mugford HM, Murdoch J, Harrey I. Leukotriene antagonists as first-line or add-on asthma-controller therapy. N Engl J Med 2011; 364: 1695–1707.
   PubMed Web of Science ®Google Scholar
• Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs P, O’Toole S, Myint SH, Tyrrel DA. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ 1995; 310:1225–1229.
   PubMed Web of Science ®Google Scholar
• Lee SL, Chiu SS, Malik PJ, Chan KH, Wong HS, Lau YL. Is respiratory viral infection really an important trigger of asthma exacerbations in children? Eur J Pediatr 2011; 170:1317–1324.
   PubMed Web of Science ®Google Scholar
• Eisner MD, Iribarren C. The influence of cigarette smoking on adult asthma outcomes. Nicotine Tob Res 2007; 9:53–56.
   PubMed Web of Science ®Google Scholar
• Rodrigo GJ, Plaza V. Body Mass Index and response to emergency department treatment in adults with severe asthma exacerbations: A prospective Cohort study. Chest 2007; 132:1513–1519.
   PubMed Web of Science ®Google Scholar
• Boudreaux ED, Emond SD, Clark S, Camargo Jr CA. Acute asthma among adults presenting to the emergency department: The Role of Race/Ethnicity and Socioeconomic Status. Chest 2003; 124: 803–812.
   PubMed Web of Science ®Google Scholar
• Osborne ML, Pedula KL, O’Hollaren M, Ettinger KM, Stibolt T, Buist AS, Vollmer WM. Assessing future need for acute care in adult asthmatics: The Profile of Asthma Risk Study: A prospective health maintenance organization-based study. Chest 2007; 132:1151–1161.
   PubMed Web of Science ®Google Scholar